Physician profile
Billy Jack Pence
NPI 1588647390
$599.91
in general payments reported to CMS, 2019-2025
12 companies · $261 in 2025
The $261 reported for 2025 was more than what a typical Internal Medicine provider received nationally (typical 2025 total: $156).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2021: $124 · 2023: $13.82 · 2024: $201 · 2025: $261.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $475.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $475.45 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Boehringer Ingelheim Pharmaceuticals, INC. | $124.46 | 2021 | |
| Novo Nordisk INC | $99.97 | 2024-2025 | Ozempic, Rybelsus |
| Lilly USA, LLC | $80.09 | 2024-2025 | Mounjaro, Zepbound |
| Astrazeneca Pharmaceuticals LP | $63.90 | 2023-2025 | Breztri, Farxiga, Airsupra |
| Pfizer INC. | $46.61 | 2024-2025 | |
| Exact Sciences Corporation | $44.92 | 2024-2025 | The Cologuard Plus Collection Kit, Cologuard Collection Kit |
| Seqirus USA INC | $39.10 | 2025 | Flucelvax, Fluad |
| Abbott Laboratories | $24.47 | 2024 | Octrode |
| Sanofi Pasteur INC. | $24.06 | 2025 | |
| Corium, LLC | $18.59 | 2024 | Azstarys |
| Inari Medical, INC. | $18.35 | 2024 | Ct Thrombectomy System Kit, Flowtriever Catheter, S |
| Corcept Therapeutics | $15.39 | 2025 | Korlym |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Billy Pence listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.